Progress, application and challenges of liver organoids

被引：0
作者：
Chen Sang
Jian Lin
Shuyi Ji
Qiang Gao
机构：
[1] Liver Cancer Institute,Department of Liver Surgery and Transplantation
[2] Zhongshan Hospital,Jinshan Hospital Center for Tumor Diagnosis & Therapy
[3] Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education,undefined
[4] Fudan University,undefined
[5] Jinshan Hospital,undefined
[6] Fudan University,undefined
来源：
Clinical Cancer Bulletin | / 3卷 / 1期
关键词：
Liver organoids; Stem cells; Cancer organoids; Disease modeling; Methods;
D O I：
10.1007/s44272-024-00012-0
中图分类号：
学科分类号：
摘要：
The liver, the largest solid organ in the body, is susceptible to metabolic diseases and malignant tumors. Studying its physiological and pathological processes helps to optimize the clinical treatment. Organoids are a novel tool for studying physical development, disease mechanisms, and high-throughput drug screening due to their similarity in composition, structure, and function to internal organs. Recent studies have shown that stem cells, hepatocytes, or cholangiocytes can form “liver organoids” under the synergistic action of specific extracellular matrix and various signaling molecules. This review outlines techniques for generating liver organoids that maximally recapitulate the liver structure and functions in vitro and thoroughly discusses the customary applications of organoids derived from liver tissue, induced pluripotent stem cells (iPSCs) and liver tumors. In this review, a meticulous analysis is provided of the comparatively advanced culture systems used in the construction of liver cancer-derived organoids. Additionally, we reviewed the progress of liver organoids in disease modeling, drug efficacy, and toxicity evaluation, in hopes of generating innovative ideas for the research and applications of liver organoids.
引用
收藏
相关论文
共 385 条
  • [1] Llovet JM(2021)Hepatocellular carcinoma Nat Rev Dis Primers 7 6-1608
  • [2] Kelley RK(2016)Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy Int J Cancer 138 1601-156
  • [3] Villanueva A(2020)Transgenic zebrafish for modeling hepatocellular carcinoma MedComm (2020). 1 140-16
  • [4] Ju HL(2013)A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity Toxicol Appl Pharmacol 268 1-9096
  • [5] Han KH(2012)Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems Biomaterials 33 9087-277
  • [6] Lee JD(2017)Modeling physiological events in 2D vs. 3D cell culture Physiology (Bethesda). 32 266-388
  • [7] Nakayama J(2019)Induced pluripotent stem cells in disease modelling and drug discovery Nat Rev Genet 20 377-1261
  • [8] Gong Z(2018)Animal models of biliary injury and altered bile acid metabolism Biochim Biophys Acta Mol Basis Dis. 1864 1254-254
  • [9] Kostadinova R(2016)Organoids as an in vitro model of human development and disease Nat Cell Biol 18 246-641
  • [10] Boess F(2019)Robust, long-term culture of endoderm-derived hepatic organoids for disease modeling Stem Cell Rep 13 627-404
12345678910